TPG Biotech Advisors, Inc.

CIK 1666545 · last filed 2017-06-02

TPG Biotech Advisors, Inc. is a corporate insider who has filed 1 SEC Form 4 insider transactions across 1 company since 2017. The most recent filing shows the insider sold $2.60B of Q on Jun 2, 2017. Across all open-market trades the lifetime net is −$2.60B, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.56B across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$5.56B

Companies

1

Total Filings

1

Lifetime Open-Market Net

-$2.60B

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
Q	Director	36,935,608	$150.65	$5.56B	-$2.60B	1	2017-06-02

Recent Filings

1 filing

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2017-06-02	Q	Sell (S)	−30,929,616	-$2.60B	EDGAR

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.